Digestibility of Selected Resistant Starches in Humans
NCT01939600 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2014-11-18
Summary
Dietary fiber is a type of carbohydrate which is not digested in the human small intestine. Whole grains are a source of dietary fiber that are used to promote health; however, using whole grains in commercial products results in a different taste and/or texture than the usual products made from refined grains. Thus, other types of high-fiber ingredients have been developed which can be incorporated into food products with less effect on their taste and/or texture. An example of this is resistant starch, defined as starch which is not digested in the human small intestine. The digestibility of starch is usually determined in-vitro; however, there is evidence that such methods may overestimate the amount of resistant starch by as much as 100%. The measurement of the amount of carbohydrate in the ileal effluent, digestive waste, of subjects with an ileostomy is considered to be the best in-vivo method of starch digestibility. The subjects collect ileal effluent during the day during which time they consume a polysaccharide-free diet. There is evidence that resistant starch consumed at breakfast is completely recovered in ileal effluent 8-10hr after consumption. The purpose of this study will be to compare the carbohydrate content recovered in ileal effluent of 10 subjects with a conventional ileostomy.
Conditions
- Malabsorption; Carbohydrate
- Ileostomy - Stoma
Interventions
- OTHER
-
Starch-free breakfast
Starch-free breakfast alone
- OTHER
-
Hi-Maize 260
Starch-free breakfast plus 55.3g Hi-Maize 260
- OTHER
-
Hylon VII
Starch-free breakfast plus 56.9g Hylon VII
- OTHER
-
Amioca
Starch-free breakfast plus 56.4g amioca starch
Sponsors & Collaborators
-
Ingredion Incorporated
collaborator INDUSTRY -
University of Toronto
collaborator OTHER -
Glycemic Index Laboratories, Inc
collaborator INDUSTRY -
Iowa State University
collaborator OTHER -
Unity Health Toronto
lead OTHER
Principal Investigators
-
Thomas M. Wolever, MD, PhD · Unity Health Toronto
Study Design
- Allocation
- NA
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2013-12-31
- Completion
- 2014-08-31
Countries
- Canada
Study Locations
More Related Trials
-
Resistant Starch on Glucose and Insulin Sensitivity in Individuals With Type 2 Diabetes
NCT00691249 ·Status: COMPLETED ·Phase: NA
-
Effect of Prebiotics on the Gut Microbiome Profile and Beta Cell Function
NCT04114357 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Resistant Starch in a Beverage on Post-prandial Glycemic and Insulinemic Responses
NCT02161250 ·Status: COMPLETED ·Phase: NA
-
Comparison of Different Types of Resistant Starch
NCT00930956 ·Status: COMPLETED ·Phase: NA
-
Effects of Resistant Starch in a Baked Snack Bar on a Post-prandial Glycemic and Insulinemic Response
NCT02187913 ·Status: UNKNOWN ·Phase: NA
-
Application of Raw Corn Starch on Patients With Insulinoma
NCT03930368 ·Status: UNKNOWN ·Phase: NA
-
Soluble Fibre Enriched CHO Food Study
NCT01898026 ·Status: UNKNOWN ·Phase: NA
-
Food Containing Resistant Starch Type 4 and Postprandial Glycemic Response
NCT03844503 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Glycemic Responses to Nutritional Products
NCT05179031 ·Status: COMPLETED ·Phase: NA
-
Human Faecal Microbiota in Type 2 Diabetes
NCT02694172 ·Status: COMPLETED ·Phase: NA
-
Effect of Resistant Starch Type 4 on Glycemia and Insulin Sensitivity in Young Adults
NCT00687960 ·Status: COMPLETED ·Phase: NA
-
Glycogen Storage Disease Breath Test Study
NCT03218904 ·Status: COMPLETED ·Phase: NA
-
Comparison of Nutritional Products for People With Type 2 Diabetes
NCT00520065 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Resistant Starch Bagels on Risk Factors of Type 2 Diabetes and Colorectal Cancer
NCT02129946 ·Status: COMPLETED ·Phase: NA
-
Effect of Fiber on Glycemic Index
NCT02615327 ·Status: COMPLETED ·Phase: NA
-
Assessing Gut Microbiota Mediated Health Outcomes of Whole Wheat and Its Major Bioactive Components
NCT05318183 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
OPTIFIT-Optimal Fiber Trial for Diabetes Prevention
NCT01681173 ·Status: COMPLETED ·Phase: NA
-
Examining the Feasibility of Prolonged Ketone Concentrate Supplement Drink Consumption in Adults With Type 2 Diabetes
NCT05983562 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Fibre Grain Herb Trial in Type 2 Diabetes
NCT02553382 ·Status: COMPLETED ·Phase: NA
-
Intestinimonas for Prevention of Type 2 Diabetes Mellitus
NCT04495972 ·Status: COMPLETED ·Phase: NA
-
Prebiotics, Gut Microbiota, and Cardiometabolic Health
NCT02346838 ·Status: COMPLETED ·Phase: NA
-
Reduction of the Dietary Glycemic Index (GI) by L-Arabinose and Indigestible Dextrin
NCT01039662 ·Status: COMPLETED ·Phase: NA
-
Effect of Varying the Protein and Dietary Fiber Content of Energy Bars on Their Glycemic and Insulinemic Impact
NCT02537587 ·Status: COMPLETED ·Phase: NA
-
Effects of Novel Fiber on Glucose Metabolism and Insulin Sensitivity
NCT01375803 ·Status: COMPLETED ·Phase: NA
-
Post-prandial Glycemic Response to Fiber in Healthy Adults
NCT03252704 ·Status: COMPLETED ·Phase: NA